Literature DB >> 18781880

Time trend of the prevalence of hepatitis E antibodies among farmers and blood donors: a potential zoonosis in Denmark.

Peer B Christensen1, Ronald E Engle, Charlotte Hjort, Keld M Homburg, Werner Vach, Jørgen Georgsen, Robert H Purcell.   

Abstract

BACKGROUND: Antibody to hepatitis E virus (anti-HEV) is prevalent in Western countries, where clinical hepatitis E is rarely reported. The aim of this study was to determine the prevalence of anti-HEV among Danish blood donors and Danish farmers. In addition, we compared the prevalence among 2 sets of serum samples obtained from blood donors 20 years apart.
METHODS: Samples from 291 Danish farmers and 169 blood donors that were collected in 1983 and samples from 461 blood donors that were collected in 2003 were tested for anti-HEV. Relevant information on HEV exposure was collected by self-administered questionnaire.
RESULTS: Anti-HEV testing was performed on samples after 20 years of storage at -20 degrees C. The prevalence of anti-HEV was 50.4% among farmers and 32.9% among donors in 1983 and 20.6% among donors in 2003 (P < .05). Presence of anti-HEV was significantly correlated with increasing age in all 3 groups (P < .05). Among donors who had serum samples obtained in 2003, age, contact with horses, and the presence of antibody to hepatitis A virus were associated with the presence of anti-HEV in multivariate analysis. Among farmers, only age was independently associated with the presence of anti-HEV.
CONCLUSION: Anti-HEV was highly prevalent among Danes but has decreased in prevalence over the past 50 years. Our study supports the hypothesis that HEV infection in Denmark may be an asymptomatic zoonotic infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18781880      PMCID: PMC2803052          DOI: 10.1086/591970

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  39 in total

1.  A novel virus in swine is closely related to the human hepatitis E virus.

Authors:  X J Meng; R H Purcell; P G Halbur; J R Lehman; D M Webb; T S Tsareva; J S Haynes; B J Thacker; S U Emerson
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

2.  Sporadic hepatitis E in Austria.

Authors:  H C Worm; H Wurzer; G Frösner
Journal:  N Engl J Med       Date:  1998-11-19       Impact factor: 91.245

3.  Transmission of hepatitis E in Germany.

Authors:  W J Hartmann; G G Frösner; D Eichenlaub
Journal:  Infection       Date:  1998 Nov-Dec       Impact factor: 3.553

4.  Comparison of tests for antibody to hepatitis E virus.

Authors:  T M Ghabrah; S Tsarev; P O Yarbough; S U Emerson; G T Strickland; R H Purcell
Journal:  J Med Virol       Date:  1998-06       Impact factor: 2.327

5.  Prevalence of and risk factors for antibody to hepatitis E virus seroreactivity among blood donors in Northern California.

Authors:  E E Mast; I K Kuramoto; M O Favorov; V R Schoening; B T Burkholder; C N Shapiro; P V Holland
Journal:  J Infect Dis       Date:  1997-07       Impact factor: 5.226

6.  Hepatitis A immunity in the Swedish population. A study of the prevalence of markers in the Swedish population.

Authors:  M Böttiger; B Christenson; L Grillner
Journal:  Scand J Infect Dis       Date:  1997

7.  Evaluation of assays for antibody to hepatitis E virus by a serum panel. Hepatitis E Virus Antibody Serum Panel Evaluation Group.

Authors:  E E Mast; M J Alter; P V Holland; R H Purcell
Journal:  Hepatology       Date:  1998-03       Impact factor: 17.425

8.  Seroreactivity to hepatitis E virus in areas where the disease is not endemic.

Authors:  D L Thomas; P O Yarbough; D Vlahov; S A Tsarev; K E Nelson; A J Saah; R H Purcell
Journal:  J Clin Microbiol       Date:  1997-05       Impact factor: 5.948

9.  Age-specific prevalence of antibodies to hepatitis A and E viruses in Pune, India, 1982 and 1992.

Authors:  V A Arankalle; S A Tsarev; M S Chadha; D W Alling; S U Emerson; K Banerjee; R H Purcell
Journal:  J Infect Dis       Date:  1995-02       Impact factor: 5.226

10.  Genetic and experimental evidence for cross-species infection by swine hepatitis E virus.

Authors:  X J Meng; P G Halbur; M S Shapiro; S Govindarajan; J D Bruna; I K Mushahwar; R H Purcell; S U Emerson
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

View more
  62 in total

1.  Clinical and epidemiological aspects of a hepatitis E outbreak in Bangui, Central African Republic.

Authors:  Alice I Goumba; Xavier Konamna; Narcisse P Komas
Journal:  BMC Infect Dis       Date:  2011-04-14       Impact factor: 3.090

2.  Reverse transcription-loop-mediated isothermal amplification assay for rapid detection of hepatitis E virus.

Authors:  Xi Lan; Bin Yang; Bao Yu Li; Xiang Ping Yin; Xue Rui Li; Ji Xing Liu
Journal:  J Clin Microbiol       Date:  2009-04-29       Impact factor: 5.948

3.  Genotype 3 diversity and quantification of hepatitis E virus RNA.

Authors:  Florence Abravanel; Karine Sandres-Saune; Sebastien Lhomme; Martine Dubois; Jean-Michel Mansuy; Jacques Izopet
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

Review 4.  Hepatitis E: an old infection with new implications.

Authors:  Giuseppe Marano; Stefania Vaglio; Simonetta Pupella; Giuseppina Facco; Maria Bianchi; Gabriele Calizzani; Fabio Candura; Liviana Catalano; Blandina Farina; Monica Lanzoni; Vanessa Piccinini; Giancarlo M Liumbruno; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2014-09-12       Impact factor: 3.443

5.  Seroepidemiology of HEV and HAV in two populations with different socio-economic levels and hygienic/sanitary conditions.

Authors:  M Zuin; C Caserta; L Romanò; A Mele; A Zanetti; R Cannatelli; A Giorgini; C Tagliacarne; A Amante; F Marcucci; P M Battezzati
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-10-26       Impact factor: 3.267

Review 6.  Host immune status and response to hepatitis E virus infection.

Authors:  Lisa J Krain; Kenrad E Nelson; Alain B Labrique
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

Review 7.  Autochthonous hepatitis e virus infections: a new transfusion-associated risk?

Authors:  Jens Dreier; David Juhl
Journal:  Transfus Med Hemother       Date:  2013-12-30       Impact factor: 3.747

8.  The mystery of hepatitis E seroprevalence in developed countries: is there subclinical infection due to hepatitis E virus?

Authors:  Mohamed T Shata; Udayakumar Navaneethan
Journal:  Clin Infect Dis       Date:  2008-10-15       Impact factor: 9.079

9.  Seroprevalence of hepatitis E virus (HEV) in humans living in high pig density areas of Germany.

Authors:  Andi Krumbholz; Sebastian Joel; Paul Dremsek; Anne Neubert; Reimar Johne; Ralf Dürrwald; Mario Walther; Thomas H Müller; Detlef Kühnel; Jeannette Lange; Peter Wutzler; Andreas Sauerbrei; Rainer G Ulrich; Roland Zell
Journal:  Med Microbiol Immunol       Date:  2014-04-18       Impact factor: 3.402

10.  Comparison of real-time PCR and antigen assays for detection of hepatitis E virus in blood donors.

Authors:  T Vollmer; C Knabbe; J Dreier
Journal:  J Clin Microbiol       Date:  2014-04-16       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.